Cargando…
Leptomeningeal Metastases: New Opportunities in the Modern Era
Leptomeningeal metastases arise from cancer cell entry into the subarachnoid space, inflicting significant neurologic morbidity and mortality across a wide range of malignancies. The modern era of cancer therapeutics has seen an explosion of molecular-targeting agents and immune-mediated strategies...
Autores principales: | Wilcox, Jessica A., Li, Min Jun, Boire, Adrienne A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723010/ https://www.ncbi.nlm.nih.gov/pubmed/35790709 http://dx.doi.org/10.1007/s13311-022-01261-4 |
Ejemplares similares
-
Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases
por: Wilcox, Jessica A., et al.
Publicado: (2022) -
Palliation for all people: alleviating racial disparities in supportive care for brain metastases
por: Wilcox, Jessica A, et al.
Publicado: (2020) -
Advances in the diagnosis, evaluation, and management of leptomeningeal disease
por: Sener, Ugur, et al.
Publicado: (2021) -
Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery
por: Freret, Morgan E., et al.
Publicado: (2022) -
BSLD-05 ESTABLISHMENT AND CHARACTERIZATION OF MOUSE MODELS OF LEPTOMENINGEAL METASTASIS
por: Derderian, Camille, et al.
Publicado: (2023)